The Global L-carnitine Market size, and Forecast 2021 to 2028

L-Carnitine Market to 2027 - Global Analysis and Forecasts by Process (Chemical Synthesis, Bio-process); Product (Food, Pharmaceutical Grade, Feed Grade); Application (Animal Feed, Healthcare Products, Functional Drinks, Medicines)

  • Report Code : TIPRE00010170
  • Category : Food and Beverages
  • Status : Published
  • No. of Pages : 147
Buy Now

The L-carnitine market was valued at US$ 172.2 million in 2018 and is projected to reach US$ 262.6 million by 2027; it is expected to grow at a CAGR of 4.8% from 2019 to 2027.

L- Carnitine is an amino acid present in every cell of a human body, and it transports fatty acids to mitochondria, thereby helping in energy production. It functions as the engine inside a body, by burning the fats and creating usable energy out of them. A human body requires plenty of vitamin c to produce L-carnitine. It also serves as a nutrient and dietary supplement. L-Carnitine can be produced by consuming meat and fishes. L-Carnitine is known to enhance post-exercise recovery in older people.

Asia Pacific is estimated to register the fastest CAGR in the L- Carnitine market over the forecast period. The rapid growth of this region is primarily attributed to the rising awareness related to health benefits and rich nutritional profile offered by the products prepared from L-Carnitine. Due to the increase rate of lifestyle-related diseases, people are opting for a healthier lifestyle and food. L-Carnitine is increasingly consumed by users for weight management amid growing obesity across the world. Moreover, some studies also claim L-Carnitine to have antitumor and anti-cancer activities Further, it also helps in preventing heart-related diseases in patients who cannot synthesize L-Carnitine on their own. The increasing incidences of cardiovascular diseases in people of Asia countries has driven significant consumers towards opting for L-Carnitine supplements. Rising affluence, burgeoning consumer spending on preventive healthcare products, and increasing incidences of chronic diseases has augmented the sales of L-Carnitine based products. The growing popularity of L-Carnitine based functional drinks and beverages marketed as endurance promoting has led to significant consumption of L-Carnitine in recent period. Further, the growing demand for L-Carnitine in animal nutrition is projected to drive the market growth in the Asia Pacific region..

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

L-Carnitine Market: Strategic Insights

l-carnitine-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Market Insights

Growing Demand for L-Carnitine as Additive in Animal Feed

L-Carnitine has been deemed efficient in increasing body weight gain and feed conversion in chickens, quails, piglets, and fish. L-Carnitine is increasingly used as additives in swine feeds to promote growth in pigs during their grower and finisher stages. The increasing consumption of L-Carnitine in swine nutrition to increase body weight and increase rib fat depth in sows is likely to give an impetus to the L-Carnitine market in the forecast period. The crucial role played by L-Carnitine in the swine industry to increase the total litter weight at birth and at weaning stages is also likely to spur the growth of L-Carnitine. Applications of L-Carnitine as a feed additive in the expanding poultry industry are also expected to create significant opportunities. The growing uses of L-Carnitine in formulating chicken feed to promote lipid distribution in broilers, improving egg promotion, and hatchability is likely to augment the consumption of LCarnitine in chicken nutrition. The fast-expanding animal husbandry and meat industry, coupled with increasing consumption of meat products to meet nutritional requirements across the world, has generated substantial demand for highly functional animal feed additives. The availability of meat at affordable prices and burgeoning meat consumption per capita is expected to foster the growth of the animal husbandry industry and subsequently promote the consumption of L-Carnitine in animal nutrition during the forecast period.

Process Insights

Based on process, the L-carnitine market has been segmented into chemical synthesis and bio-process. The market for bio-process is expected to grow at a higher CAGR during the forecast period. Bioprocess is a method employed in the production of L-Carnitine owing to its highest yield and the environmental benefits that it offers. An upsurge in demand for commercial product compels manufacturers to improve their production process to increase the yield. Biological processes making use of microorganisms and enzymes are inherently asymmetric processes. The most commonly used bioprocess that generates highest yield is based on the biotransformation of achiral precursors like 3- dehydrocarnitine, crotonobetaine and y-butyrobetaine or racemic mixtures such as D, L-carnitine, D, L-acyl carnitine and D, L –carnitinamide. Both, D-carnitine and crotonobetaine can be used as a biotransformation substrate for the production of l-carnitine. Increased productivity of L-Carnitine is also achieved by using a genetically modified strain overproducing the multifunctional protein CaiD that forms a part of both carnitine dehydrate (CDH) and carnitine racemase (CRac) activities. However, compared to the classical chemical method of racemate synthesis involving resolution of the enantiomers, the use of fed-batch cultivation of rhizobium like a strain for the enantioselective production of the racemate, involves 50% less of total organic waste, 25% less of water and 90% less water for incineration.

Product Insights

Based on product, the L-carnitine market has been bifurcated into food, pharmaceutical grade, and feed grade. The pharmaceutical grade segment is expected to register the fastest growth rate during the forecast period. The pharmaceutical grade of L-Carnitine is used for human consumption in various applications like post –exercise recovery, weight management, male fertility, infant nutrition and healthy aging. NutraBio L-Carnitine is a pharmaceutical-grade amino acid that is tested for potency in the HPLC lab and is guaranteed to be free from any kind of harmful impurities. Dymatize Nutrition L-Carnitine Xtreme contains 100% pure pharmaceutical L-Carnitine. The L-Carnitine is similar to the nonessential amino acid carnitine and also helps in supporting muscle growth and development. It also helps in fat burning, improving resistance to muscle fatigue, and also helps in losing weight without feeling weak. Preliminary research has conveyed that supplementation with L-Carnitine both intravenously and orally may slow down the death of lymphocytes, thereby decreasing the rate of HIV progression in an HIV infected individual. Besides this, L-Carnitine in pharmaceutical-grade also helps in the treatment of various other diseases like cancer, type 2 diabetes, and AIDS..

Application Insights

Based on application, the L-carnitine market has been segmented into animal feed, healthcare products, functional drinks, and medicines. The functional drinks segment is expected to register the fastest growth rate during the forecast period. Bioprocess is a method employed in the production of L-Carnitine owing to its highest yield and the environmental benefits that it offers. An upsurge in demand for commercial product compels manufacturers to improve their production process to increase the yield. Biological processes making use of microorganisms and enzymes are inherently asymmetric processes. The most commonly used bioprocess that generates highest yield is based on the biotransformation of achiral precursors like 3- dehydrocarnitine, crotonobetaine and y-butyrobetaine or racemic mixtures such as D, L-carnitine, D, L-acyl carnitine and D, L –carnitinamide. Both, D-carnitine and crotonobetaine can be used as a biotransformation substrate for the production of l-carnitine. Increased productivity of L-Carnitine is also achieved by using a genetically modified strain overproducing the multifunctional protein CaiD that forms a part of both carnitine dehydrate (CDH) and carnitine racemase (CRac) activities. However, compared to the classical chemical method of racemate synthesis involving resolution of the enantiomers, the use of fed-batch cultivation of rhizobium like a strain for the enantioselective production of the racemate, involves 50% less of total organic waste, 25% less of water and 90% less water for incineration.

Mergers &acquisition and research &development are commonly adopted by companies to expand their footprint worldwide, which is further impacting the size of the market. The players present in the markethave been implementing the several strategies to enlarge the customer base and to gain significant market share across the world, which also permits the players to maintain their brand name globally.

The L-carnitine Market Report Scope

L-Carnitine Market Regional Insights

The regional trends and factors influencing the L-Carnitine Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses L-Carnitine Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

l-carnitine-market-global-geography
  • Get the Regional Specific Data for L-Carnitine Market

L-Carnitine Market Report Scope

Report Attribute Details
Market size in 2018 US$ 172.2 Million
Market Size by 2027 US$ 262.6 Million
Global CAGR (2018 - 2027) 4.8%
Historical Data 2016-2017
Forecast period 2019-2027
Segments Covered By Process
  • Chemical Synthesis
  • Bio-process
By Product
  • Food
  • Pharmaceutical Grade
  • Feed Grade
By Application
  • Animal Feed
  • Healthcare Products
  • Functional Drinks
  • Medicines
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Alpsure Life Sciences Pvt. Ltd.
  • Biosint S.p.A
  • Cayman Chemical
  • ChengDa PharmaCeuticals Co., Ltd.
  • HuangGang HuaYang Pharmaceutical Co., Ltd.
  • Kaiyuan Hengtai Nutrition Co., Ltd.
  • Lonza Group Ltd.
  • Maxsun Industries Incorporated
  • MERCK KGaA
  • Market Players Density: Understanding Its Impact on Business Dynamics

    The L-Carnitine Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

    Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

    Major Companies operating in the L-Carnitine Market are:

    1. Alpsure Life Sciences Pvt. Ltd.
    2. Biosint S.p.A
    3. Cayman Chemical
    4. ChengDa PharmaCeuticals Co., Ltd.
    5. HuangGang HuaYang Pharmaceutical Co., Ltd.

    Disclaimer: The companies listed above are not ranked in any particular order.


    l-carnitine-market-speedometer

    • Get the L-Carnitine Market top key players overview

    Report Spotlights 

    • Progressive industry trends in the global L-carnitine market to help players develop effective long-term strategies
    • Business growth strategies adopted by developed and developing markets
    • Quantitative analysis of the global L-carnitine market from 2017 to 2027
    • Estimation of global L-carnitine demand across various industries
    • PEST analysis to illustrate the efficacy of buyers and suppliers operating in the industry to predict market growth
    • Recent developments to understand the competitive market scenario and global L-carnitine demand
    • Market trends and outlook coupled with factors driving and restraining the growth of the global L-carnitine market
    • Decision-making process by understanding strategies that underpin commercial interest with regard to global L-carnitine market growth
    • Global L-carnitine market size at various nodes of market
    • Detailed overview and segmentation of the global L-carnitine market, as well as its dynamics in the industry
    • Global L-carnitine market size in various regions with promising growth opportunities

    By Process

    • Chemical Synthesis
    • Bio-process

    By Product

    • Food
    • Pharmaceutical Grade
    • Feed Grade

    By Application 

    • Animal Feed
    • Healthcare Products
    • Functional Drinks
    • Medicines

    Company Profiles

    • ChengDaPharmaCeuticals Co., Ltd
    • Maxsun Industries Incorporated
    • ALPSURE LIFESCIENCES PVT. LTD
    • HuangGangHuaYang Pharmaceutical Co., Ltd
    • Kaiyuan Hengtai Nutrition Co., Ltd
    • Lonza Group Ltd
    • Northeast Pharmaceutical Group Co., Ltd
    • Cayman Chemical
    • MERCK KGaA
    • Biosint S.p.A.
    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset
    Report Coverage

    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered

    Segment Covered

    Process ; Product ; Application

    Regional Scope

    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope

    Country Scope

    Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

    Frequently Asked Questions


    Mention some of the major players operating in the global L-Carnitine market?

    The major players operating in the global L-Carnitine market, includes Alpsure Lifesciences Pvt. Ltd, Biosint S.p.A., Cayman Chemical, Cheng Da PharmaCeuticals Co., Ltd, Huang Gang Hua Yang Pharmaceutical Co., Ltd, Kaiyuan Hengtai Nutrition Co., Ltd., Lonza Group Ltd, Maxsun Industries Incorporated, Merck KGaA, and Northeast Pharmaceutical Group Co., Ltd, and among many others.

    In 2018, which region accounted to hold the largest share for the global L-Carnitine market?

    The L-Carnitine market was led by the North America region at a global level. The demand for L-Carnitine is expected to increase in the region with the rising demand from the pharmaceuticals & dietary supplements application as it is known to increase endurance and reduce fatigue. Moreover, daily consumption of L-Carnitine minimizes the risk of death from cardiovascular disorders. Therefore, raising awareness about the health benefits offered by L-Carnitine is boosting the market growth in the North America region.

    On the basis of process, the bioprocess segment is expected to grow at a faster pace during the forecast period of 2019-2027, why?

    The bioprocess segment is expected to grow at a faster pace over the forecast period. Bioprocess is a method employed in the production of L-Carnitine owing to its highest yield and the environmental benefits that it offers. An upsurge in demand for commercial product compels manufacturers to improve their production process to increase the yield.

    Trends and growth analysis reports related to Food and Beverages : READ MORE..   

    The List of Companies - L-Carnitine Market

    1. Alpsure Life Sciences Pvt. Ltd.
    2. Biosint S.p.A
    3. Cayman Chemical
    4. ChengDa PharmaCeuticals Co., Ltd.
    5. HuangGang HuaYang Pharmaceutical Co., Ltd.
    6. Kaiyuan Hengtai Nutrition Co., Ltd.
    7. Lonza Group Ltd.
    8. Maxsun Industries Incorporated
    9. MERCK KGaA
    10. Northeast Pharmaceutical Group Co., Ltd.